Rezolute (RZLT.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov12

Rezolute, Inc. holds investor event to discuss Ersodetug development project

11:57

Nov7

H.C. Wainwright analyst reiterates Buy rating on Rezolute

12:02

Rezolute released FY2026 Q1 earnings on November 6 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1754 (forecast USD -0.2642)

04:00

Nov6

Rezolute Inc. Advances RZ358 Drug Clinical Trials

21:27

Nov5

Rezolute Inc. to Host Virtual Investor Event Highlighting Latest Ersodetug Progress

12:30

Oct30

Citizens Jmp Raises Rezolute's Target Price to $17

16:45

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2026 Q1 Earning Release (USD) Net Income -18.15 M, EPS -0.1754

Sep17

Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -24.39 M, EPS -0.2592

May13

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -18.91 M, EPS -0.27

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More